Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04534608
What this trial is testing

COVID-19 Child Health Investigation of Latent Disease in Hamburg

Who this might be right for
SARS-CoV-2Covid19
Universitätsklinikum Hamburg-Eppendorf 6,000
Not applicableUnknownNCT05083026
What this trial is testing

Neutralizing Antibody Level After COVID-19 Vaccination

Who this might be right for
Covid19
Kyungpook National University Hospital 51
Not applicableUnknownNCT04446338
What this trial is testing

Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre

Who this might be right for
History of Covid-19, Seroprevalence
University Hospital Tuebingen 300
Not applicableUnknownNCT05124535
What this trial is testing

Population-based Age-stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection in the Federation of Bosnia and Herzegovina

Who this might be right for
SeroprevalenceAntibodyCOVID-19
Institute for Public Health of the Federation of Bosnia and Herzegovina 1,152
Not applicableStudy completedNCT04810117
What this trial is testing

Monitoring the IgG/IgM Antibodies in COVID-19 Patients

Who this might be right for
COVID-19 Infections
University of Sargodha 373
Not applicableStudy completedNCT05054218
What this trial is testing

COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

Who this might be right for
Covid19SARS-CoV2 Infection
H. Lee Moffitt Cancer Center and Research Institute 336
Not applicableEnded earlyNCT05142540
What this trial is testing

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines

Who this might be right for
Anti-SARS-CoV-2 Antibody Response
Medical University of Graz 140
Testing effectiveness (Phase 2)Study completedNCT04371367
What this trial is testing

Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )

Who this might be right for
COVID
Assistance Publique Hopitaux De Marseille 208
Large-scale testing (Phase 3)Study completedNCT04341116
What this trial is testing

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Disease 2019 COVID-19
I-Mab Biopharma US Limited 149
Testing effectiveness (Phase 2)Ended earlyNCT04432272
What this trial is testing

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus Infections
Corewell Health East 71
Early research (Phase 1)Ended earlyNCT05092581
What this trial is testing

COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724834
What this trial is testing

CD19-B Cell Depletion in PAIS-ME/CFS Patients

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID 19 Condition (PCC or Long COVID)Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Charite University, Berlin, Germany 38
Not applicableWithdrawnNCT04594395
What this trial is testing

Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableUnknownNCT04822012
What this trial is testing

Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid

Who this might be right for
SARS-CoV-2
Meir Medical Center 50
Not applicableStudy completedNCT04768244
What this trial is testing

Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health

Who this might be right for
Covid19
Institute of Agrochemistry and Food Technology, National Research Council 100
Large-scale testing (Phase 3)Ended earlyNCT06524739
What this trial is testing

Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

Who this might be right for
Post-COVID Postural Orthostatic Tachycardia Syndrome
CSL Behring 16
Not applicableStudy completedNCT04932967
What this trial is testing

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

Who this might be right for
Covid19Hematological Malignancy
Gruppo Italiano Malattie EMatologiche dell'Adulto 91
Not applicableUnknownNCT05012306
What this trial is testing

Covid-19 Antibody Responses in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Universitätsklinikum Köln 500
Not applicableStudy completedNCT05338762
What this trial is testing

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

Who this might be right for
SARS-CoV2 Infection
MiCo BioMed Co., Ltd. 218
Testing effectiveness (Phase 2)UnknownNCT05200754
What this trial is testing

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Carsten Müller-Tidow 174
Next Page